2-Aminophenol Hemisulfate Salt | CAS:67845-79-8

We serve 2-Aminophenol Hemisulfate Salt CAS:67845-79-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Aminophenol Hemisulfate Salt

Chemical Name:2-Aminophenol Hemisulfate Salt
CAS.NO:67845-79-8
Synonyms:2-Aminophenol hemisulfate;
Molecular Formula:C12H16N2O6S
Molecular Weight:316.33000
 
Physical and Chemical Properties:
Boiling point:609.7oC;
 
Specification:
Appearance:Light grey crystal
Purity(HPLC):≥99.0%
Ash:≤0.5%
Loss on drying:≤0.5%
Fe content:≤100ppm
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Hair dyes intermediate



Contact us for information like 2-Aminophenol Hemisulfate Salt chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Aminophenol hemisulfate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Aminophenol Hemisulfate Salt Use and application,2-Aminophenol hemisulfate technical grade,usp/ep/jp grade.


Related News: As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials.2-(4-bromophenyl)triphenylene manufacturer As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials.Methyl (11Z)-11-icosenoate supplier The main API products include antihypertensive, psychotropic and anti-AIDS special APIs. Antihypertensive APIs are mainly pulic and sartan drugs, and they are the world’s major suppliers of pulic and sartan APIs.4-Chlorophenylboronic acid vendor The risk to the UK population has been raised from very low to low, according to Public Health England, which says the country is “well prepared for new diseases”.Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.